Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
What are you searching for?
Enclose phrases in quotes. Use a + to require a term in results and - to exclude terms.
Example: +water -Europe
Subscribe
Research
Biotech
Clinical Data
Venture Capital
Deals
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Cell & Gene Therapy
COVID-19
Emerging Biopharma
Podcasts
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
MedTech
MedTech
Alzheimer’s risk predicted years early with unique blood test
Researchers at King’s College London found a person’s risks of Alzheimer’s years before diagnosis by evaluating their ability to form new brain cells.
Conor Hale
Jan 27, 2023 11:35am
ResMed tops $1B in Q2 revenues as Philips’ CPAP recall rages on
Jan 27, 2023 11:18am
Ex-Neuralink exec’s brain implant startup raises $41M
Jan 27, 2023 10:08am
Rockley Photonics files for bankruptcy
Jan 26, 2023 12:21pm
Abbott spinal cord stimulator nets FDA approval in diabetes pain
Jan 26, 2023 11:21am
Getinge recalls heart balloon pumps after patient death
Jan 26, 2023 10:34am
More News
Abbott ekes out 1.3% growth in 2022 amid COVID testing drop-off
Jan 25, 2023 12:13pm
A new dimension: Biotech VC unveils with $350M
Jan 25, 2023 11:31am
Intuitive's profit dips as sales, robot surgery volumes increase
Jan 25, 2023 11:16am
Tidepool lands long-awaited FDA nod for diabetes management app
Jan 25, 2023 10:33am
See more